Stock·NYSE·Basic Materials
Nucor Corporation (NUE)
- Market cap
- $61.44B
- P/E
- 21.59
- Dividend yield
- 0.83%
- Street target
- $290.50median of 17 analysts
- 52-week range
- $140.93 $280.11
NUE stock forecast today
Where NUE stands today, and what CleaRank Financial AI makes of it.
NUE at a glance
Nucor Corporation (NUE): Strong Buy, 85/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($252.44 and $222.43).
- Earnings NUE beat estimates in 6 of its last 7 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $72.1M and made no open-market purchases over the last 18 months.
- Valuation P/E of 21.6 against 30.2 for the Basic Materials sector: a discount to peers (-29%).
Figures as of October 27, 2026.
CleaRank Financial AI
Nucor Corporation (NUE) carries a CleaRank rating of Strong Buy and a score of 85/100.
The trend contributes most to that score. The price is 21.74% above its 200-day average and 7.27% above its 50-day average, and the 50-day average is 13.49% above the 200-day, which stands at $222.43. The 50-day average itself is $252.44. Across the past year, the stock rose 87.84%.
Only on CleaRank
Figures we compute ourselves from NUE's own price, earnings and insider-filing history. Tap one to see it in context.
NUE stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $270.79 is 7.3% above the 50-day simple moving average of $252.44.Price above its 200-day average ›
The price is 21.7% above the 200-day simple moving average of $222.43.50-day average above the 200-day ›
The 50-day average ($252.44) is 13.5% above the 200-day average ($222.43), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 93% of its 52-week range, between $140.93 and $280.11.
NUE share price
Pick a period: each tab shows how far NUE has moved over it, to the last close.
Today's trading
Where NUE sits inside today's range and its 52-week range.
NUE fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 21.59 is 28.5% below the Basic Materials median of 30.2.P/S below the sector median ›
The price-to-sales ratio of 1.70 is 59.5% below the sector median of 4.2.Profitable over the last 12 months ›
Net income over the last 12 months was $2.9B on revenue of $36.1B, a net margin of 8.0%.Beat estimates in most recent reports ›
NUE beat the EPS estimate in 6 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 0.83%, or $2.24 a share a year.
Key statistics
The headline figures for NUE.
As of October 27, 2026, NUE trades at $270.79, with a market value of $61.44B, a P/E ratio of 21.59 and a dividend yield of 0.83%.
What the numbers say
CleaRank Financial AI's reading of NUE's valuation, growth and risks.
Nucor Corporation (NUE) trades at 21.59 times earnings, against a Basic Materials median of 30.2. That places the P/E 28.5% below the sector median, a discount to peers. Its market capitalisation stands at $61.4B, and trailing earnings are $12.54 a share.
NUE turns sales into profit at a net margin of 7.99% and an operating margin of 15.67%, alongside a return on equity of 14.55%, below the sector median of 17.9%. The balance sheet and payout round out the picture, with debt-to-equity of 0.31 and a trailing dividend yield of 0.83% ($2.24 a share a year).
Nucor Corporation (NUE) beat estimates in its July 27, 2026 report, with EPS of $4.84 against the $4.53 analysts had expected, a beat of 6.84%. In the first session after the report, the share price rose 7.17%.
NUE has beaten the EPS estimate in 6 of its last 7 reports, yet the stock fell in the first session after 1 of those 6 beats. Further back, the stock rose 5.43% after the October 27, 2025 report, which beat the estimate by 21.20%. Looking ahead, analysts expect EPS of $19.49 for this fiscal year and $20.95 for next year, an expected growth rate of 7.5%.
NUE's daily returns have a 30-day standard deviation of 2.18%, and the stock carries a beta of 1.85 against the S&P 500. Over the last 18 months, insiders sold $72.1M worth of shares and made no open-market purchases. Such sales are often planned ahead or made to cover taxes on vesting shares, so they tell a weaker story than buying would.
NUE against the Basic Materials sector
How NUE compares with the median Basic Materials stock CleaRank tracks.
Price to earnings vs sector: NUE trades at a notable discount to sector peers (-29%), which may indicate undervaluation or specific company headwinds.
Return vs XLB: Since May 15, 2025, NUE has gained 134.5% against a gain of 20.2% for XLB.
Performance against XLB
NUE and the Basic Materials sector fund over the same days.
Revenue and earnings
How much NUE sells, and how much of it becomes profit.
The quarterly bars end with Q1 '26 (the quarter to March 31, 2026); NUE reported again on July 27, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 5.7% in FY2025 to $32.5B, from $30.7B a year earlier.
Profit margin: The net margin was 6.3% in FY2025, down from 7.5% the year before.
Profitable: NUE earned $2.0B in FY2025.
Earnings reality check
Did NUE beat what analysts expected, and how did the stock react?
Earnings record: NUE beat the analyst estimate in 6 of the last 7 quarters.
Market reaction: The stock fell in the first session after 1 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 27, 2026after close | $4.53 | $4.84 | +6.84% | +7.17% | +5.41% |
| Apr 27, 2026after close | $2.82 | $3.23 | +14.54% | +4.70% | +5.03% |
| Jan 26, 2026after close | $1.81 | $1.73 | -4.42% | -2.30% | +1.86% |
| Oct 27, 2025after close | $2.17 | $2.63 | +21.20% | +5.43% | +2.75% |
| Jul 28, 2025after close | $2.64 | $2.65 | +0.38% | -2.68% | -5.22% |
| Apr 28, 2025after close | $0.66 | $0.77 | +16.67% | +1.89% | +3.36% |
| Jan 27, 2025after close | $0.62 | $1.22 | +96.77% | +3.76% | +7.65% |
As of October 27, 2026, NUE has beaten the analyst EPS estimate in 6 of its last 7 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on July 27, 2026, came in 6.84% above the estimate and the stock moved +7.17% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
NUE AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 65.9, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 65.9 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of NUE
The score, the reasoning behind it, and what could move the price next.
Nucor Corporation (NUE) is trading at $270.79, above both of its main moving averages. The stock is 7.27% above its 50-day average of $252.44 and 21.74% above its 200-day average of $222.43. Near the top of its 52-week range, the price is 3.33% below the high of $280.11 and 92.15% above the low of $140.93. With the 50-day average 13.49% above the 200-day, the averages back up the advance instead of pointing against it.
The 14-day RSI of 65.9 is in the bullish zone, below the overbought line, and the MACD line is positive. The recent returns are all positive: the price rose 1.95% over the past three months, rose 20.29% over the past six months and rose 87.84% over the past year. Volume in the last session ran 75.3% above its average, on a day the price rose 5.22%.
Earnings beat ›
The July 27, 2026 report beat the EPS estimate by 6.84%, and the share price rose 7.17% in the first session after it.
Source: Earnings report, July 27, 2026Rating reaffirmed ›
Barclays kept its Overweight rating on October 19, 2026.
Source: Analyst action, Barclays, October 19, 2026
Analyst downgrade ›
Freedom Broker downgraded it to Hold from Buy on September 18, 2026.
Source: Analyst action, Freedom Broker, September 18, 2026
- The two nearest levels to watch are the 52-week high at $280.11, above the price, and the 20-day EMA at $256.25, below it.
- The 14-day RSI reads 65.9, in the bullish zone, with the MACD line positive; readings above 70 or below 30 mark stretched momentum.
- In the first session after the July 27, 2026 report, the share price rose 7.17%. Over the last 7 reports, NUE beat estimates in 6 of them.
The uptrend rests on NUE staying above its 50-day average at $252.44 and its 200-day average at $222.43; a close below the 50-day would be the first crack in it. On a pullback, the first level the price would meet is the 20-day EMA at $256.25.
Nucor Corporation (NUE) has the 52-week high of $280.11 as its next level overhead.
Technical indicators
Momentum and trend for NUE, from its daily closes.
As of October 27, 2026, with NUE at $270.79, its 14-day RSI is 65.9 (showing bullish momentum without being overbought), its 50-day simple moving average is $252.44 and its 200-day is $222.43.
Calculated by CleaRank on daily closes as of October 27, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What NUE moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 27, 2026, NUE's 1-year correlation of daily returns is +0.51 with S&P 500 (SPY), +0.42 with Nasdaq 100 (QQQ), +0.04 with Bitcoin (BTC) and +0.06 with gold (XAU).
NUE price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
13 of 17 analysts rate it a buy or strong buy, 3 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $290.50 is 7.3% above the price.More buy ratings than three months ago ›
13 of 17 rate it a buy now, against 14 of 17 three months ago.
NUE Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 19, 2026 | Barclays | Maintains | Overweight |
| Oct 9, 2026 | JP Morgan | Maintains | Overweight |
| Oct 5, 2026 | Keybanc | Maintains | Overweight |
| Sep 18, 2026 | Freedom Broker | Downgrade | Hold |
| Sep 18, 2026 | Wells Fargo | Maintains | Overweight |
| Sep 9, 2026 | JP Morgan | Maintains | Overweight |
As of October 27, 2026, 17 Wall Street analysts cover NUE: 13 rate it a buy or strong buy, 3 a hold and 1 a sell or strong sell. Their 12-month price targets range from $226.00 to $310.00. The median NUE price target is $290.50, 7.3% above the price of $270.79.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
NUE trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
NUE trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from NUE's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much NUE tends to move, against the market and on its own.
NUE price history and drawdowns
NUE's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 2.18% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 55.2%, from January 2018 to March 2020, regained by March 2021.Most 1-year holds ended higher ›
65% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $70,200, against $42,376 in the S&P 500 (SPY).
NUE Drawdowns & Recovery
As of October 27, 2026, NUE's worst peak-to-trough fall over the last 10 years with dividends reinvested was -55.2% (January 2018 to March 2020); it regained that peak by March 2021, 12 months after the low, and 65% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into NUE in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: NUE beat the S&P 500 over this period: $70,200 against $42,376.
A $10,000 investment in NUE in October 2016 would be worth about $70,200 today with dividends reinvested, compared with about $42,376 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to NUE, and which have not.
Strongest month, November: an average of +7.60%, up in 8 of 10 years.
Weakest month, September: an average of -4.84%, up in 3 of 10 years.
This month, October: has averaged +4.63%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, NUE's strongest calendar month has been November (average +7.60%, up in 8 of 10 years) and its weakest September (average -4.84%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
NUE stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in NUE, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in NUE today could grow to about $14,680 by 2030 in the base case, with a 90th-percentile outcome near $37,165 and a 10th-percentile outcome around $5,799. The simulation models price only; at today's 0.83% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
NUE Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $398 for NUE by 2030 in the base case, from $271 today (1.5x over 4 years). The 10th-percentile path ends near $157. These are outcomes of a Monte Carlo simulation run on NUE's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $187 | $298 | $474 | |
| 2028 | $170 | $328 | $633 | |
| 2029 | $162 | $361 | $807 | |
| 2030 | $157 | $398 | $1,006 |
Method: a lognormal simulation of NUE's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
NUE insider trading
What the people running the company have bought and sold.
NUE insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought NUE shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 27, 2026, NUE insiders reported 32 open-market sales worth $72.1M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 17, 2026 | Leon J Topalian
Chief Executive Officer
|
Grant | 1.8K | - |
| Aug 14, 2026 | Leon J Topalian
Chief Executive Officer
|
Sell | 26.0K | $7.0M |
| Aug 14, 2026 | Allen C. Behr
Officer
|
Sell | 7.7K | $2.1M |
| Aug 14, 2026 | Allen C. Behr
Officer
|
Option | 7.7K | $857.0K |
| Aug 14, 2026 | Leon J Topalian
Chief Executive Officer
|
Option | 26.0K | $1.1M |
| Aug 3, 2026 | Thomas J. Batterbee
Officer
|
Sell | 4.0K | $1.0M |
| Jul 30, 2026 | Stephen D. Laxton
President
|
Sell | 4.0K | $1.0M |
| Jul 30, 2026 | Stephen D. Laxton
President
|
Grant | 2.4K | - |
| Jun 3, 2026 | John J Hollatz
Officer
|
Sell | 10.6K | $2.7M |
| Jun 3, 2026 | John J Hollatz
Officer
|
Option | 10.6K | $1.4M |
| Jun 1, 2026 | Kenneth Rex Query
Officer
|
Sell | 13.5K | $3.4M |
| Jun 1, 2026 | Thomas J. Batterbee
Officer
|
Grant | 1.6K | - |
| Jun 1, 2026 | Allen C. Behr
Officer
|
Grant | 2.9K | - |
| Jun 1, 2026 | Norma Clayton
Director
|
Grant | 755 | $189.9K |
| Jun 1, 2026 | Patrick J Dempsey Jr
Director
|
Grant | 755 | - |
| Jun 1, 2026 | Bradley Ford
Officer
|
Grant | 2.9K | - |
| Jun 1, 2026 | Nicholas C. Gangestad
Director
|
Grant | 755 | - |
| Jun 1, 2026 | Noah C Hanners
Officer
|
Grant | 2.9K | - |
| Jun 1, 2026 | John J Hollatz
Officer
|
Grant | 2.9K | - |
| Jun 1, 2026 | Christopher J Kearney
Director
|
Grant | 755 | - |
| Jun 1, 2026 | Michael D Keller
Officer
|
Grant | 717 | - |
| Jun 1, 2026 | Laurette T Koellner
Director
|
Grant | 755 | - |
| Jun 1, 2026 | Michael W Lamach
Director
|
Grant | 755 | - |
| Jun 1, 2026 | Stephen D. Laxton
President
|
Grant | 3.5K | - |
| Jun 1, 2026 | Daniel R. Needham
Officer
|
Grant | 2.9K | - |
| Jun 1, 2026 | Benjamin M Pickett
Officer
|
Grant | 1.6K | - |
| Jun 1, 2026 | Kenneth Rex Query
Officer
|
Grant | 2.9K | - |
| Jun 1, 2026 | Randy J. Spicer
Officer
|
Grant | 2.9K | - |
| Jun 1, 2026 | John Leo Sullivan III
Chief Financial Officer
|
Grant | 1.7K | - |
| Jun 1, 2026 | David A Sumoski
Officer
|
Grant | 3.5K | - |
| Jun 1, 2026 | Leon J Topalian
Chief Executive Officer
|
Grant | 12.0K | - |
| Jun 1, 2026 | Nadja Y. West
Director
|
Grant | 755 | - |
| May 18, 2026 | Randy J. Spicer
Officer
|
Sell | 2.5K | $562.5K |
| May 15, 2026 | Leon J Topalian
Chief Executive Officer
|
Sell | 52.0K | $11.8M |
| May 15, 2026 | Leon J Topalian
Chief Executive Officer
|
Option | 52.0K | $2.2M |
| May 5, 2026 | Bradley Ford
Officer
|
Sell | 2.2K | $520.0K |
| May 4, 2026 | Allen C. Behr
Officer
|
Sell | 10.1K | $2.3M |
| May 4, 2026 | Michael D Keller
Officer
|
Sell | 4.6K | $1.0M |
| May 1, 2026 | Daniel R. Needham
Officer
|
Sell | 12.9K | $2.9M |
| May 1, 2026 | Noah C Hanners
Officer
|
Sell | 6.5K | $1.5M |
| May 1, 2026 | Daniel R. Needham
Officer
|
Option | 7.7K | $857.0K |
| Apr 30, 2026 | David A Sumoski
Officer
|
Sell | 33.1K | $7.5M |
| Apr 30, 2026 | David A Sumoski
Officer
|
Option | 33.1K | $1.4M |
| Mar 23, 2026 | Leon J Topalian
Chief Executive Officer
|
Sell | 11.5K | $1.9M |
| Mar 23, 2026 | Leon J Topalian
Chief Executive Officer
|
Grant | 3.8K | - |
| Mar 10, 2026 | Stephen D. Laxton
President
|
Grant | 823 | $139.6K |
| Mar 10, 2026 | Daniel R. Needham
Officer
|
Grant | 1.4K | $241.6K |
| Mar 10, 2026 | Benjamin M Pickett
Officer
|
Grant | 478 | $81.1K |
| Mar 10, 2026 | John Leo Sullivan III
Chief Financial Officer
|
Grant | 316 | $53.7K |
| Mar 10, 2026 | David A Sumoski
Officer
|
Grant | 823 | $139.6K |
| Mar 10, 2026 | Leon J Topalian
Chief Executive Officer
|
Grant | 2.0K | $345.3K |
| Feb 19, 2026 | Thomas J. Batterbee
Officer
|
Grant | 2.2K | - |
| Feb 19, 2026 | Allen C. Behr
Officer
|
Grant | 5.3K | - |
| Feb 19, 2026 | Bradley Ford
Officer
|
Grant | 4.3K | - |
| Feb 19, 2026 | Noah C Hanners
Officer
|
Grant | 4.6K | - |
| Feb 19, 2026 | John J Hollatz
Officer
|
Grant | 4.9K | - |
| Feb 19, 2026 | Michael D Keller
Officer
|
Grant | 1.4K | - |
| Feb 19, 2026 | Stephen D. Laxton
President
|
Grant | 5.4K | - |
| Feb 19, 2026 | Daniel R. Needham
Officer
|
Grant | 5.1K | - |
| Feb 19, 2026 | Benjamin M Pickett
Officer
|
Grant | 2.0K | - |
| Feb 19, 2026 | Kenneth Rex Query
Officer
|
Grant | 5.1K | - |
| Feb 19, 2026 | Randy J. Spicer
Officer
|
Grant | 3.3K | - |
| Feb 19, 2026 | David A Sumoski
Officer
|
Grant | 6.0K | - |
| Feb 19, 2026 | Leon J Topalian
Chief Executive Officer
|
Grant | 22.2K | - |
| Feb 11, 2026 | Kenneth Rex Query
Officer
|
Sell | 7.5K | $1.5M |
| Feb 3, 2026 | Allen C. Behr
Officer
|
Sell | 15.1K | $2.8M |
| Feb 3, 2026 | Allen C. Behr
Officer
|
Option | 15.1K | $639.8K |
| Jan 30, 2026 | Daniel R. Needham
Officer
|
Sell | 3.9K | $690.8K |
| Dec 23, 2025 | Thomas J. Batterbee
Officer
|
Sell | 2.0K | $330.6K |
| Dec 23, 2025 | Thomas J. Batterbee
Officer
|
Grant | 593 | - |
| Dec 19, 2025 | Allen C. Behr
Officer
|
Sell | 6.0K | $939.4K |
| Dec 19, 2025 | Leon J Topalian
Chief Executive Officer
|
Sell | 5.0K | $790.0K |
| Nov 12, 2025 | John J Hollatz
Officer
|
Sell | 7.0K | $1.0M |
| Oct 30, 2025 | Allen C. Behr
Officer
|
Sell | 9.0K | $1.4M |
| Oct 30, 2025 | Stephen D. Laxton
Chief Financial Officer
|
Sell | 2.0K | $303.6K |
| Oct 30, 2025 | Stephen D. Laxton
Chief Financial Officer
|
Grant | 2.1K | - |
| Aug 22, 2025 | Michael D Keller
Officer
|
Sell | 6.1K | $903.5K |
| Aug 18, 2025 | Kenneth Rex Query
Officer
|
Sell | 10.0K | $1.4M |
| Aug 18, 2025 | Daniel R. Needham
Officer
|
Sell | 7.2K | $1.1M |
| Jul 31, 2025 | Leon J Topalian
Chief Executive Officer
|
Sell | 29.8K | $4.3M |
| Jul 31, 2025 | Allen C. Behr
Officer
|
Sell | 8.0K | $1.2M |
| Jun 26, 2025 | Kenneth Rex Query
Officer
|
Sell | 10.0K | $1.3M |
| Jun 24, 2025 | Daniel R. Needham
Officer
|
Sell | 7.1K | $906.3K |
| May 30, 2025 | Thomas J. Batterbee
Officer
|
Grant | 3.0K | - |
| May 30, 2025 | Allen C. Behr
Officer
|
Grant | 6.8K | - |
| May 30, 2025 | Norma Clayton
Director
|
Grant | 1.6K | $169.9K |
| May 30, 2025 | Patrick J Dempsey Jr
Director
|
Grant | 1.6K | - |
| May 30, 2025 | Bradley Ford
Officer
|
Grant | 6.8K | - |
| May 30, 2025 | Noah C Hanners
Officer
|
Grant | 6.8K | - |
| May 30, 2025 | John J Hollatz
Officer
|
Grant | 6.8K | - |
| May 30, 2025 | Christopher J Kearney
Director
|
Grant | 1.6K | - |
| May 30, 2025 | Michael D Keller
Officer
|
Grant | 1.7K | - |
| May 30, 2025 | Laurette T Koellner
Director
|
Grant | 1.6K | $169.9K |
| May 30, 2025 | Michael W Lamach
Director
|
Grant | 1.6K | - |
| May 30, 2025 | Stephen D. Laxton
Chief Financial Officer
|
Grant | 8.4K | - |
| May 30, 2025 | Gregory Joseph Murphy
Officer
|
Grant | 6.8K | - |
| May 30, 2025 | Daniel R. Needham
Officer
|
Grant | 6.8K | - |
| May 30, 2025 | Benjamin M Pickett
Officer
|
Grant | 3.0K | - |
| May 30, 2025 | Kenneth Rex Query
Officer
|
Grant | 6.8K | - |
| May 30, 2025 | Randy J. Spicer
Officer
|
Grant | 6.8K | - |
| May 30, 2025 | David A Sumoski
Chief Operating Officer
|
Grant | 8.4K | - |
| May 30, 2025 | Leon J Topalian
Chief Executive Officer
|
Grant | 28.3K | - |
| May 30, 2025 | Douglas Chad Utermark
Officer
|
Grant | 6.8K | - |
| May 30, 2025 | Nadja Y. West
Director
|
Grant | 1.6K | - |
| May 1, 2025 | Leon J Topalian
Chief Executive Officer
|
Sell | 34.2K | $4.1M |
Source: TwelveData, from SEC Form 4 filings
NUE stock forecast: questions people ask
Answered from the figures on this page, as of October 27, 2026.